We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-3.38%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$43.6M
AUM Growth
-$446M
(-91%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-1,013.48%
Top 10 Holdings %
Top 10 Hldgs %
28.16%
Holding
580
New
77
Increased
4
Reduced
27
Closed
472
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.24M |
| 2 |
TSMC
TSM
|
+$1.13M |
| 3 |
NuScale Power
SMR
|
+$1.11M |
| 4 |
Trade Desk
TTD
|
+$1.02M |
| 5 |
Microchip Technology
MCHP
|
+$910K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$5.39M |
| 2 |
Accenture
ACN
|
+$5.35M |
| 3 |
CRWV
CoreWeave
CRWV
|
+$4.97M |
| 4 |
Robinhood
HOOD
|
+$4.87M |
| 5 |
Expedia Group
EXPE
|
+$4.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.63% |
| 2 | Healthcare | 13.02% |
| 3 | Communication Services | 12.94% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Douglas Emmett
DEI
$2.06B
| $119K | 0.27% |
+10,799
| New | +$135K |
|
102
Novavax
NVAX
$1.23B
| $117K | 0.27% |
17,374
+7,100
| +69% | +$53.5K |
|
103
Huntsman Corp
HUN
$2.24B
| $113K | 0.26% |
+11,300
| New | +$103K |
|
104
Shoals Technologies Group
SHLS
$1.58B
| $111K | 0.25% |
+13,000
| New | +$117K |
|
105
Goodyear
GT
$2.07B
| $98.1K | 0.22% |
+11,200
| New | +$88.3K |
|
106
Gogo Inc
GOGO
$515M
| $87.2K | 0.2% |
+18,721
| New | +$137K |
|
107
Iovance Biotherapeutics
IOVA
$2.23B
| $41.8K | 0.1% |
+15,300
| New | +$35.4K |
|
108
Milestone Pharmaceuticals
MIST
$144M
| $34.8K | 0.08% |
+17,215
| New | +$37.1K |
|
109
Apple
AAPL
$4.89T
| – | – |
-15,800
| Closed | -$4.02M |
|
110
AbbVie
ABBV
$458B
| – | – |
-14,400
| Closed | -$3.33M |
|
111
Airbnb
ABNB
$83.7B
| – | – |
-7,400
| Closed | -$899K |
|
112
Arbor Realty Trust
ABR
$960M
| – | – |
-18,200
| Closed | -$222K |
|
|
ACB
113
Aurora Cannabis
ACB
$165M
| – | – |
-11,100
| Closed | -$66.2K |
|
114
ACI Worldwide
ACIW
$5.72B
| – | – |
-12,800
| Closed | -$675K |
|
115
Aecom
ACM
$9.07B
| – | – |
-5,178
| Closed | -$676K |
|
|
116
Accenture
ACN
$89.9B
| – | – |
-21,699
| Closed | -$5.35M |
|
117
Adeia
ADEA
$2.86B
| – | – |
-11,300
| Closed | -$190K |
|
118
Analog Devices
ADI
$181B
| – | – |
-4,700
| Closed | -$1.15M |
|
119
Adaptive Biotechnologies
ADPT
$3.56B
| – | – |
-17,658
| Closed | -$264K |
|
120
Autodesk
ADSK
$44.3B
| – | – |
-7,457
| Closed | -$2.37M |
|
121
Ameren
AEE
$31.5B
| – | – |
-7,385
| Closed | -$771K |
|
122
Aegon
AEG
$13.5B
| – | – |
-64,000
| Closed | -$511K |
|
123
American Eagle Outfitters
AEO
$2.85B
| – | – |
-98,886
| Closed | -$1.69M |
|
124
AES
AES
$10.6B
| – | – |
-13,900
| Closed | -$183K |
|
125
AdaptHealth
AHCO
$1.46B
| – | – |
-16,400
| Closed | -$147K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Bayesian Capital Management held 580 positions worth $43.6M, down 91% from $490M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Bayesian Capital Management withdrew a net $442M in Q4 2025, closing 472 positions and reducing 27 holdings. Its most notable exit was Boston Scientific, an estimated $5.39M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Bayesian Capital Management opened a new position in JPMorgan Chase worth $1.29M.
- Bayesian Capital Management's largest Q4 2025 buy was JPMorgan Chase: 4,000 shares worth $1.29M.
- Bayesian Capital Management added most to TSMC in Q4 2025, an estimated $1.13M increase.
- Bayesian Capital Management's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $4.54M.
- Bayesian Capital Management fully exited Boston Scientific in Q4 2025, selling an estimated $5.39M.
- Bayesian Capital Management's ten largest holdings make up 28% of its $43.6M portfolio in Q4 2025.
- Bayesian Capital Management opened 77 new positions and closed 472 in Q4 2025.
- Bayesian Capital Management's portfolio value fell 91% quarter-over-quarter to $43.6M.
Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.